1. Home
  2. APLM vs SOGP Comparison

APLM vs SOGP Comparison

Compare APLM & SOGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • SOGP
  • Stock Information
  • Founded
  • APLM 2016
  • SOGP 2010
  • Country
  • APLM United States
  • SOGP Singapore
  • Employees
  • APLM N/A
  • SOGP N/A
  • Industry
  • APLM Blank Checks
  • SOGP
  • Sector
  • APLM Finance
  • SOGP
  • Exchange
  • APLM Nasdaq
  • SOGP NYSE
  • Market Cap
  • APLM 6.9M
  • SOGP 6.9M
  • IPO Year
  • APLM N/A
  • SOGP 2020
  • Fundamental
  • Price
  • APLM $6.49
  • SOGP $5.98
  • Analyst Decision
  • APLM
  • SOGP
  • Analyst Count
  • APLM 0
  • SOGP 0
  • Target Price
  • APLM N/A
  • SOGP N/A
  • AVG Volume (30 Days)
  • APLM 7.8K
  • SOGP 1.9M
  • Earning Date
  • APLM 08-13-2025
  • SOGP 07-15-2025
  • Dividend Yield
  • APLM N/A
  • SOGP N/A
  • EPS Growth
  • APLM N/A
  • SOGP N/A
  • EPS
  • APLM N/A
  • SOGP N/A
  • Revenue
  • APLM $198,000.00
  • SOGP $278,363,908.00
  • Revenue This Year
  • APLM $415.15
  • SOGP $48.88
  • Revenue Next Year
  • APLM N/A
  • SOGP N/A
  • P/E Ratio
  • APLM N/A
  • SOGP N/A
  • Revenue Growth
  • APLM N/A
  • SOGP N/A
  • 52 Week Low
  • APLM $4.47
  • SOGP $1.18
  • 52 Week High
  • APLM $35.98
  • SOGP $6.20
  • Technical
  • Relative Strength Index (RSI)
  • APLM 47.85
  • SOGP 77.70
  • Support Level
  • APLM $6.21
  • SOGP $3.71
  • Resistance Level
  • APLM $6.80
  • SOGP $6.00
  • Average True Range (ATR)
  • APLM 0.52
  • SOGP 0.77
  • MACD
  • APLM 0.00
  • SOGP 0.31
  • Stochastic Oscillator
  • APLM 51.61
  • SOGP 95.28

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)

Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.

Share on Social Networks: